Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial

C. H. Choi; J. G. Kwon; S. K. Kim; S.-J. Myung; K. S. Park; C.-I. Sohn; P.-L. Rhee; K. J. Lee; O. Y. Lee; H.-K. Jung; S. R. Jee; Y. T. Jeen; M.-G. Choi; S. C. Choi; K. C. Huh; H. Park

doi:10.1111/nmo.12544

Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial

Neurogastroenterology & Motility ◽

10.1111/nmo.12544 ◽

2015 ◽

Vol 27 (5) ◽

pp. 705-716 ◽

Cited By ~ 14

Author(s):

C. H. Choi ◽

J. G. Kwon ◽

S. K. Kim ◽

S.-J. Myung ◽

K. S. Park ◽

...

Keyword(s):

Combination Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Phase

Download Full-text

Su2068 Efficacy of Combination Therapy of Probiotics and Mosapride in Patients With IBS Without Diarrhea: Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II Trial

Gastroenterology ◽

10.1016/s0016-5085(13)62030-2 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-547

Author(s):

Chang Hwan Choi ◽

Joong Goo Kwon ◽

Sung-Kook Kim ◽

Seung-Jae Myung ◽

Kyung Sik Park ◽

...

Keyword(s):

Combination Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Phase

Download Full-text

A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk

PLoS ONE ◽

10.1371/journal.pone.0117560 ◽

2015 ◽

Vol 10 (2) ◽

pp. e0117560 ◽

Cited By ~ 7

Author(s):

Ying Li ◽

Xiao-hui Li ◽

Zhi-jun Huang ◽

Guo-ping Yang ◽

Guo-gang Zhang ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Phase ◽

Hypertensive Population ◽

Medium Risk

Download Full-text

Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer

Head & Neck ◽

10.1002/hed.25115 ◽

2018 ◽

Vol 40 (7) ◽

pp. 1375-1388 ◽

Cited By ~ 7

Author(s):

Daniel A. Hamstra ◽

Kuei C. Lee ◽

Avraham Eisbruch ◽

Prasad Sunkara ◽

Sudhir Borgonha ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Oral Mucositis ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Phase

Download Full-text

265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2020.10.259 ◽

2020 ◽

Vol 31 ◽

pp. S1347

Author(s):

Y. Chi ◽

M. Gao ◽

Y. Zhang ◽

F. Shi ◽

Y. Cheng ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Differentiated Thyroid Carcinoma ◽

Double Blind ◽

Multicenter Phase

Download Full-text

A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)

European Journal of Cancer ◽

10.1016/j.ejca.2015.10.012 ◽

2016 ◽

Vol 53 ◽

pp. 144-154 ◽

Cited By ~ 19

Author(s):

Konstantinos Tryfonidis ◽

Gul Basaran ◽

Jan Bogaerts ◽

Marc Debled ◽

Luc Dirix ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

European Organisation ◽

Hormone Receptor Positive

Download Full-text

Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase-II Trial: AdrenoMedullin for Ischemic Stroke Study

Journal of Stroke and Cerebrovascular Diseases ◽

10.1016/j.jstrokecerebrovasdis.2021.105761 ◽

2021 ◽

Vol 30 (6) ◽

pp. 105761

Author(s):

Takeshi Yoshimoto ◽

Satoshi Saito ◽

Katsuhiro Omae ◽

Yorito Hattori ◽

Kazuki Fukuma ◽

...

Keyword(s):

Ischemic Stroke ◽

Phase Ii ◽

Study Protocol ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Stroke Study

Download Full-text

P5‐106: Japanese, multicenter, phase II trial of combination therapy with favipiravir and methylprednisolone for COVID‐19 patients with non‐critical respiratory failure: the J‐critical trial

Respirology ◽

10.1111/resp.14150_313 ◽

2021 ◽

Vol 26 (S3) ◽

pp. 200-200

Keyword(s):

Respiratory Failure ◽

Combination Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Critical Trial ◽

Multicenter Phase

Download Full-text

Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU)

Acta Dermato Venereologica ◽

10.2340/00015555-3120 ◽

2019 ◽

Vol 99 (4) ◽

pp. 379-385 ◽

Cited By ~ 19

Author(s):

A Tsianakas ◽

C Zeidler ◽

C Riepe ◽

M Borowski ◽

C Forner ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Early Survival of Comatose Patients after Severe Traumatic Brain Injury with the Dual Cannabinoid CB1/CB2 Receptor Agonist KN38-7271: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial

Journal of Neurological Surgery Part A Central European Neurosurgery ◽

10.1055/s-0032-1304815 ◽

2012 ◽

Vol 73 (04) ◽

pp. 204-216 ◽

Cited By ~ 7

Author(s):

Raimund Firsching ◽

Jürgen Piek ◽

Martin Skalej ◽

Veit Rohde ◽

Uwe Schmidt ◽

...

Keyword(s):

Traumatic Brain Injury ◽

Brain Injury ◽

Phase Ii ◽

Severe Traumatic Brain Injury ◽

Receptor Agonist ◽

Phase Ii Trial ◽

Cb2 Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

Early Survival

Download Full-text

Abstract P2-08-19: Exploratory biomarker analyses of FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) + paclitaxel (PAC) for early triple-negative breast cancer (TNBC)

10.1158/1538-7445.sabcs18-p2-08-19 ◽

2019 ◽

Author(s):

MJ Wongchenko ◽

M Oliveira ◽

C Saura ◽

P Nuciforo ◽

I Calvo ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Phase Ii

Download Full-text